Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125301105 | 12530110 | 5 | F | 20160623 | 20160804 | 20160706 | 20160811 | PER | PHEH2016US016384 | SANDOZ | 52.90 | YR | F | Y | 79.37000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125301105 | 12530110 | 1 | SS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | CAPSULE | QD | ||||||
| 125301105 | 12530110 | 2 | PS | ESTRADIOL. | ESTRADIOL | 1 | Unknown | U | 19081 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125301105 | 12530110 | 1 | Multiple sclerosis |
| 125301105 | 12530110 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125301105 | 12530110 | Anxiety | |
| 125301105 | 12530110 | Chest discomfort | |
| 125301105 | 12530110 | Drug intolerance | |
| 125301105 | 12530110 | Dyspnoea | |
| 125301105 | 12530110 | Fatigue | |
| 125301105 | 12530110 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125301105 | 12530110 | 1 | 20160621 | 20160628 | 0 |